Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. INTC
2. SPCX
3. DSX
4. GNK
5. AWK
6. MDA
7. ACN
8. NTMFF
9. III
10. SAN

Go back to Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform
(NASDAQ: KZIA) Delayed: 13.86 --0 (-0%)
Previous Close $13.86    52 Week High $ 
Open $13.86    52 Week Low $ 
Day High $13.86    P/E N/A 
Day Low $13.86    EPS $ 
Volume 304,846